UPLYFT For Lymphoma Survivors (NCT05080166) | Clinical Trial Compass
CompletedNot Applicable
UPLYFT For Lymphoma Survivors
United States74 participantsStarted 2022-02-08
Plain-language summary
The main purpose of this study is to field test and pilot an intervention called UPLYFT (Understand and Prevail: Lymphoma Fear of Recurrence Therapy) that includes information about lymphoma survivorship and tools to improve quality of life and reduce lymphoma-related worries among lymphoma survivors.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Lymphoma Survivors Phase 1 and 2:
* Diagnosis of lymphoma (indolent non-Hodgkin lymphoma, aggressive non-Hodgkin lymphoma, or classic Hodgkin lymphoma)
* Age ≥ 18 years
* Interval of 3 months to 24 months from completion of first-line treatment
* In complete remission after first line of treatment
* Clinically significant FCR (score of ≥ 16 on the validated FCR Inventory-Severity Subscale \[FCRI-SS).
* Access to computer (for videoconferencing)
Lymphoma clinicians and mental health clinicians Phase 1:
* Lymphoma clinicians ≥ 1 year from oncology fellowship completion OR mental health clinicians (psychologists, social workers, psychiatrists) ≥ 1 year from completion of clinical training.
* Longitudinal clinical care for patients with lymphoma by oncologists OR provision of care for patients with cancer by mental health clinicians
Exclusion Criteria:
Lymphoma Survivors Phase 1:
* Age \< 18 years
* Concurrent other malignancy
* Patients with uncontrolled/untreated psychotic disorders or untreated bipolar and borderline personality disorder (as ascertained from medical record screen).
Lymphoma Survivors Phase 2:
* Age \< 18 years
* Concurrent other malignancy
* Patients with uncontrolled/untreated psychotic disorders or untreated bipolar and borderline personality disorders (as ascertained from medical record screen).
* Our study will exclude members of the following special populations:
* Adults unable to consent
* Individuals who are not…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial was testing whether a survivorship program for lymphoma survivors was even feasible to run — it wasn't measuring whether it actually improved health outcomes yet, so what do we know so far about whether it helped participants, and are there follow-up studies planned?
2The trial is already completed — is there any chance I could still access the UPLYFT program or its resources outside of a clinical trial, given that it was designed specifically for lymphoma survivors like me?
3Since this was a feasibility study focused on things like how many people enrolled and completed the sessions, not on safety or treatment side effects, does that change how you'd weigh it as an option compared to other survivorship support programs?
4The trial focused on lymphoma survivorship broadly — given my specific type of lymphoma and where I am in my treatment, do you think a structured survivorship program like this one addresses the challenges I'm most likely to face?
5Now that this trial is complete, would you be able to point me toward the published results or findings, so we can discuss together whether the program's approach seems like a good fit for my recovery goals?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.